Understanding Cat CD279/PDCD1/PD1 HEK293T Stable Cell Line: Structure, Activity, and Application
Introduction
Cat CD279/PDCD1/PD1 is a cell surface receptor protein that plays a crucial role in regulating the immune response. It is primarily expressed on T cells, B cells, and natural killer cells, and is involved in the downregulation of immune responses to prevent autoimmunity and maintain self-tolerance. In recent years, Cat CD279/PDCD1/PD1 has emerged as a promising therapeutic target for various diseases, including cancer, autoimmune disorders, and infectious diseases. In this article, we will delve into the structure, activity, and application of the Cat CD279/PDCD1/PD1 HEK293T stable cell line.
Structure of Cat CD279/PDCD1/PD1
Cat CD279/PDCD1/PD1 is a type I transmembrane protein that belongs to the immunoglobulin superfamily. It is composed of 288 amino acids and has a molecular weight of approximately 33 kDa. The extracellular domain of Cat CD279/PDCD1/PD1 contains an IgV-like domain, which is responsible for binding to its ligands, PD-L1 and PD-L2. The intracellular domain of Cat CD279/PDCD1/PD1 contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM), which are crucial for its inhibitory function.
Activity of Cat CD279/PDCD1/PD1
The primary function of Cat CD279/PDCD1/PD1 is to regulate the immune response by inhibiting the activation and proliferation of T cells. This is achieved through its interaction with its ligands, PD-L1 and PD-L2, which are expressed on antigen-presenting cells and tumor cells. Upon binding to its ligands, Cat CD279/PDCD1/PD1 initiates a signaling cascade that leads to the inhibition of T cell receptor signaling and the production of anti-inflammatory cytokines, such as IL-10 and TGF-β. This results in the suppression of T cell activation and proliferation, thus preventing excessive immune responses.
Application of Cat CD279/PDCD1/PD1 HEK293T Stable Cell Line
The Cat CD279/PDCD1/PD1 HEK293T stable cell line is a valuable tool for studying the structure and function of Cat CD279/PDCD1/PD1. It is a genetically modified cell line that stably expresses Cat CD279/PDCD1/PD1, allowing for the production of large quantities of the protein for research purposes. This cell line is commonly used in flow cytometry experiments to study the expression and function of Cat CD279/PDCD1/PD1 on different immune cell populations. It can also be used in functional assays to investigate the inhibitory activity of Cat CD279/PDCD1/PD1 on T cell activation and proliferation.
In addition to its use in basic research, the Cat CD279/PDCD1/PD1 HEK293T stable cell line has significant clinical potential. It can serve as a model system for screening and developing new therapies targeting Cat CD279/PDCD1/PD1. For instance, monoclonal antibodies targeting Cat CD279/PDCD1/PD1 have shown promising results in clinical trials for the treatment of various cancers, including melanoma, lung cancer, and bladder cancer. The Cat CD279/PDCD1/PD1 HEK293T stable cell line can be used to evaluate the efficacy and safety of these therapeutic antibodies before they are tested in clinical trials.
Conclusion
In summary, Cat CD279/PDCD1/PD1 is an important immune checkpoint protein that plays a critical role in regulating the immune response.
There are no reviews yet.